We are currently working with a team that has developed an intradermal drug delivery device that offers precise control over dose, speed, depth, injection volume and needle dwell time. The device is close to market and was developed for a specific orphan disease, but we are now investigating applications across a number of alternate potential markets. The device could offer benefits to any therapeutic agent that was based on large particles, that required precise control over the location and volume of delivery or for use with patients who require multiple injections over a large area. Please contact us if you would like more details.
Comments are closed.